Norway Ai In Oncology Market Size & Outlook, 2023-2030
Norway ai in oncology market, 2018-2030 (US$M)
Related Markets
Norway ai in oncology market highlights
- The Norway ai in oncology market generated a revenue of USD 27.9 million in 2023 and is expected to reach USD 211.6 million by 2030.
- The Norway market is expected to grow at a CAGR of 33.6% from 2024 to 2030.
- In terms of segment, software solutions was the largest revenue generating component in 2023.
- Software Solutions is the most lucrative component segment registering the fastest growth during the forecast period.
Ai in oncology market data book summary
| Market revenue in 2023 | USD 27.9 million |
| Market revenue in 2030 | USD 211.6 million |
| Growth rate | 33.6% (CAGR from 2023 to 2030) |
| Largest segment | Software solutions |
| Fastest growing segment | Software Solutions |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software Solutions, Hardware, Services |
| Key market players worldwide | International Business Machines Corp, Siemens Healthineers AG ADR, Intel Corp, GE HealthCare Technologies Inc Common Stock, NVIDIA Corp |
Other key industry trends
- In terms of revenue, Norway accounted for 1.0% of the global ai in oncology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK ai in oncology market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 673.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
AI In Oncology Market Scope
AI In Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway ai in oncology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai in oncology market will help companies and investors design strategic landscapes.
Software solutions was the largest segment with a revenue share of 48.39% in 2023. Horizon Databook has segmented the Norway ai in oncology market based on software solutions, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
The AI in oncology market in Norway is driven by partnerships, product launches, and several other business initiatives, as well as various research studies being conducted to explore the potential of AI in various aspects of cancer treatment.
Furthermore, the active support from regulatory agencies and healthcare institutions is instrumental in propelling AI integration, as evidenced by the implementation of pilot programs and the provision of funding for research and development.
Furthermore, in July 2019, NEC Corporation acquired Onco Immunity AS, a bioinformatics company that develops ML software to support cancer therapy development. Onco Immunity AS became a NEC subsidiary and operated under the name of NEC Onco Immunity AS.
Reasons to subscribe to Norway ai in oncology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway ai in oncology market databook
-
Our clientele includes a mix of ai in oncology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway ai in oncology market , including forecasts for subscribers. This country databook contains high-level insights into Norway ai in oncology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway ai in oncology market size, by component, 2018-2030 (US$M)
Norway AI In Oncology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
